VRSN
59
4
CME
59
3
NEM
30
2
CAT
47
3
GILD
55
5
UHS
50
4
NRG
32
5
D
32
10
CVX
25
14
CMS
57
2
FMC
23
7
AIZ
61
5
CA
19
6
AEE
51
3
WHR
61
3
ABBV
40
5
CMCSA
49
3
ADBE
50
3
LRCX
56
4
CNP
59
17
VRSN
59
4
CME
59
3
NEM
30
2
CAT
47
3
GILD
55
5
UHS
50
4
NRG
32
5
D
32
10
CVX
25
14
CMS
57
2
FMC
23
7
AIZ
61
5
CA
19
6
AEE
51
3
WHR
61
3
ABBV
40
5
CMCSA
49
3
ADBE
50
3
LRCX
56
4
CNP
59
17
Financhill
Back

Summit Therapeutics Vs. Editas Medicine Industry Stock Comparison

Sell
31

SMMT
Summit Therapeutics

Last Price:
$17.89
Seasonality Move:
18.6%
Sell
22

EDIT
Editas Medicine

Last Price:
$1.33
Seasonality Move:
-11.28%
Sell
31
Summit Therapeutics (SMMT) is a Sell

Is Summit Therapeutics a Buy, Sell or Hold?

  • The current Summit Therapeutics [SMMT] share price is $17.87. The Score for SMMT is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • SMMT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
22
Editas Medicine (EDIT) is a Sell

Is Editas Medicine a Buy, Sell or Hold?

  • The current Editas Medicine [EDIT] share price is $1.31. The Score for EDIT is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
  • EDIT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SMMT Stock Price Chart

What is Summit Therapeutics's stock price today?

  • The Summit Therapeutics share price today is $17.87
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SMMT is experiencing selling pressure, which indicates risk of future bearish movement.

EDIT Stock Price Chart

What is Editas Medicine's stock price today?

  • The Editas Medicine share price today is $1.31
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing slight selling pressure.

SMMT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.4 Sell
Relative Strength Index (14 RSI): 45.88 Sell
Chaikin Money Flow: -4547899 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.79 - 19.07) Sell
Bollinger Bands (100): (13.59 - 22.67) Sell

EDIT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.36 Sell
Relative Strength Index (14 RSI): 23.89 Sell
Chaikin Money Flow: -1676224 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.63 - 2.43) Sell
Bollinger Bands (100): (2.37 - 4.05) Sell

SMMT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 18.12 Sell
20-day SMA: 18.32 Sell
50-day SMA: 19.47 Sell
200-day SMA: 12.04 Buy
8-day EMA: 18.07 Sell
20-day EMA: 18.39 Sell
50-day EMA: 18.72 Sell
200-day EMA: 13.66 Buy

EDIT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.54 Sell
20-day SMA: 1.92 Sell
50-day SMA: 2.6 Sell
200-day SMA: 4.58 Sell
8-day EMA: 1.53 Sell
20-day EMA: 1.88 Sell
50-day EMA: 2.47 Sell
200-day EMA: 4.44 Sell

Summit Therapeutics Earnings Growth & SMMT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.30 per share, and a decrease next year of $0.08 per share.

Editas Medicine Earnings Growth & EDIT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and an increase next year of $1.18 per share.

Summit Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Editas Medicine Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):